Cargando…

Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasia

Pazopanib (Votrient) is an orally administered tyrosine kinase inhibitor that blocks VEGF receptors potentially serving as anti-angiogenic treatment for hereditary hemorrhagic telangiectasia (HHT). We report a prospective, multi-center, open-label, dose-escalating study [50 mg, 100 mg, 200 mg, and 4...

Descripción completa

Detalles Bibliográficos
Autores principales:	Faughnan, Marie E., Gossage, James R., Chakinala, Murali M., Oh, S. Paul, Kasthuri, Raj, Hughes, Christopher C. W., McWilliams, Justin P., Parambil, Joseph G., Vozoris, Nicholas, Donaldson, Jill, Paul, Gitanjali, Berry, Pamela, Sprecher, Dennis L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2018
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510884/ https://www.ncbi.nlm.nih.gov/pubmed/30191360 http://dx.doi.org/10.1007/s10456-018-9646-1

Ejemplares similares

Pazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasia
por: Parambil, Joseph G., et al.
Publicado: (2021)

An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study
por: Al-Samkari, Hanny, et al.
Publicado: (2020)

Weekly epistaxis duration as an indicator of epistaxis severity in hereditary hemorrhagic telangiectasia—Preliminary results from a randomized controlled trial
por: Wu, Vincent, et al.
Publicado: (2021)

Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia
por: Thompson, K. P., et al.
Publicado: (2022)

Severity score for hereditary hemorrhagic telangiectasia
por: Latino, Giuseppe A, et al.
Publicado: (2014)

An analysis of sex differences in pulmonary arteriovenous malformation presentation, complications and management in a large, multinational registry of patients with hereditary haemorrhagic telangiectasia
por: Tuff-Gordon, Eliza, et al.
Publicado: (2023)

Integration of clinical parameters, genotype and epistaxis severity score to guide treatment for hereditary hemorrhagic telangiectasia associated bleeding
por: Beckman, Joan D., et al.
Publicado: (2020)

Screening for pulmonary and brain vascular malformations is the North American standard of care for patients with hereditary hemorrhagic telangiectasia (HHT): A survey of HHT Centers of Excellence
por: Kilian, Alexandra, et al.
Publicado: (2020)

Predictors of mortality in patients with hereditary hemorrhagic telangiectasia
por: Thompson, K. P., et al.
Publicado: (2021)

Bevacizumab and gastrointestinal bleeding in hereditary hemorrhagic telangiectasia
por: Ou, George, et al.
Publicado: (2016)

Circulating Angiogenic Cell Dysfunction in Patients with Hereditary Hemorrhagic Telangiectasia
por: Zucco, Liana, et al.
Publicado: (2014)

Significant Hematochezia and Intracranial Bleeding in Neonatal Hereditary Hemorrhagic Telangiectasia
por: Merves, Matthew, et al.
Publicado: (2019)

Tamoxifen Therapy for Recurrent Mucosal Bleeding in Hereditary Hemorrhagic Telangiectasia
por: Yung, Stephanie, et al.
Publicado: (2021)

Management of Refractory Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia with Bevacizumab
por: Masood, Muaaz, et al.
Publicado: (2021)

Nosebleeds in hereditary hemorrhagic telangiectasia: Development of a patient‐completed daily eDiary
por: Clark, Marci, et al.
Publicado: (2018)

Targeting under-diagnosis in hereditary hemorrhagic telangiectasia: a model approach for rare diseases?
por: Latino, Giuseppe A, et al.
Publicado: (2014)

Life expextancy of parents with Hereditary Haemorrhagic Telangiectasia
por: de Gussem, E. M., et al.
Publicado: (2016)

Association of common candidate variants with vascular malformations and intracranial hemorrhage in hereditary hemorrhagic telangiectasia
por: Pawlikowska, Ludmila, et al.
Publicado: (2018)

Utility of modified Rankin Scale for brain vascular malformations in hereditary hemorrhagic telangiectasia
por: Thompson, K. P., et al.
Publicado: (2021)

Development and performance of a hereditary hemorrhagic telangiectasia-specific quality-of-life instrument
por: Kasthuri, Raj S., et al.
Publicado: (2022)

Tacrolimus in Gastrointestinal Bleeding in a Young Boy With Hereditary Hemorrhagic Telangiectasia
por: Pruijsen, Jessica M., et al.
Publicado: (2021)

Aflibercept for Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia: A Case Report
por: Villanueva, Bernat, et al.
Publicado: (2023)

Hereditary Hemorrhagic Telangiectasia
por: Kamath, Nagesh, et al.
Publicado: (2015)

Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT)
por: Lee, John M., et al.
Publicado: (2019)

Review of Pharmacological Strategies with Repurposed Drugs for Hereditary Hemorrhagic Telangiectasia Related Bleeding
por: Albiñana, Virginia, et al.
Publicado: (2020)

Gastrointestinal Bleeding in Patients with Hereditary Hemorrhagic Telangiectasia: Risk Factors and Endoscopic Findings
por: Mora-Luján, José María, et al.
Publicado: (2019)

Functional Alterations Involved in Increased Bleeding in Hereditary Hemorrhagic Telangiectasia Mouse Models
por: Egido-Turrión, Cristina, et al.
Publicado: (2022)

The prevalence of hereditary hemorrhagic telangiectasia in Juvenile Polyposis syndrome patients with SMAD4 mutations
por: O’Malley, Margaret, et al.
Publicado: (2011)

Imaging of Hereditary Hemorrhagic Telangiectasia
por: Carette, Marie-France, et al.
Publicado: (2008)

Long-term use of somatostatin analogs for chronic gastrointestinal bleeding in hereditary hemorrhagic telangiectasia
por: Torres-Iglesias, Raquel, et al.
Publicado: (2023)

Mutations in RASA1 and GDF2 identified in patients with clinical features of hereditary hemorrhagic telangiectasia
por: Hernandez, Felicia, et al.
Publicado: (2015)

CDK6-mediated endothelial cell cycle acceleration drives arteriovenous malformations in hereditary hemorrhagic telangiectasia
por: Dinakaran, Sajeth, et al.
Publicado: (2023)

Optimal management of hereditary hemorrhagic telangiectasia
por: Garg, Neetika, et al.
Publicado: (2014)

Hereditary Hemorrhagic Telangiectasia with Unusual Associations
por: Jain, Dheeraj, et al.
Publicado: (2015)

Pericytes as targets in hereditary hemorrhagic telangiectasia
por: Thalgott, Jérémy, et al.
Publicado: (2015)

Hypercoagulability in hereditary hemorrhagic telangiectasia with epilepsy
por: Finsterer, Josef, et al.
Publicado: (2015)

Splenic Involvement in Hereditary Hemorrhagic Telangiectasia
por: Takamatsu, Susumu, et al.
Publicado: (2016)

Hereditary hemorrhagic telangiectasia with hemothorax in pregnancy
por: Raiya, Sagar, et al.
Publicado: (2017)

Hereditary Hemorrhagic Telangiectasia and Refractory Ascites
por: Thandassery, Ragesh B., et al.
Publicado: (2020)

Future treatments for hereditary hemorrhagic telangiectasia
por: Robert, Florian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s63srngqhc4f8frn8vroun97cm